The Veterinary Medicines Directorate (VMD) has released its latest update on changes to medicine authorisations most relevant to veterinary professionals. These updates include revisions to product authorisations, distribution categories, and key sections of the Summary of Product Characteristics (SPC).
Key Details for Veterinary Professionals:
Changes to SPCs, product labels, and leaflets may alter how medicines are administered. Always refer to the VMD Product Information Database (PID) for the latest details: Access the PID here.
Important Notes:
Similarly, updates to SPCs may take time to appear on product labels and literature. Unless otherwise advised, follow the instructions provided on the pack when dispensing medicines.
There may be a delay between new authorisations and the availability of updated SPCs on the PID.
Highlighted Update: Prascend 1 mg Tablets for Horses
- Manufacturer: Boehringer Ingelheim Animal Health UK Ltd
- Distribution Category: GB & NI – POM-V
- Updated SPC Section 3.6 (Adverse Reactions):
- Rare: Inappetence, anorexia, lethargy, central nervous system disorders (e.g., depression, ataxia), diarrhoea, colic.
- Very Rare: Sweating (sudation).
For full details on updates to Prascend or other products, visit the VMD Product Information Database. Always stay informed to ensure safe and effective use of veterinary medicines.
For more information, contact the VMD at postmaster@vmd.gov.uk
